KYTX (Kyverna Therapeutics) FFO


KYTX Kyverna Therapeutics Inc KYTX
12 GF Score
Price $8.44
! 1 Warning Sign
View Full Analysis

What is Kyverna Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

KYTX
12GF Score
Kyverna Therapeutics Inc KYTX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kyverna Therapeutics Business Description

Address 5980 Horton Street, Suite 550, Emeryville, CA, USA, 94608
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
12GF Score

Get the complete analysis for KYTX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.44
Price